To investigate a possible connection between the effects of the various anti-metabolic treatments on cell viability and the role of the oncogenic protein c-Myc in the regulation and control of cancer cell metabolism [25], expression of c-Myc was analyzed. The gene discussed is PROS1; the disease is cancer.